1. Home
  2. CYTK vs ORA Comparison

CYTK vs ORA Comparison

Compare CYTK & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$62.51

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Ormat Technologies Inc.

ORA

Ormat Technologies Inc.

HOLD

Current Price

$111.41

Market Cap

6.9B

Sector

Utilities

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
ORA
Founded
1997
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electric Utilities: Central
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
6.9B
IPO Year
2004
2004

Fundamental Metrics

Financial Performance
Metric
CYTK
ORA
Price
$62.51
$111.41
Analyst Decision
Strong Buy
Buy
Analyst Count
16
8
Target Price
$78.94
$117.13
AVG Volume (30 Days)
1.7M
628.7K
Earning Date
11-05-2025
11-03-2025
Dividend Yield
N/A
0.43%
EPS Growth
N/A
11.26
EPS
N/A
2.18
Revenue
$87,211,000.00
$944,248,000.00
Revenue This Year
$361.33
$11.57
Revenue Next Year
$65.14
$17.18
P/E Ratio
N/A
$50.84
Revenue Growth
2609.26
6.07
52 Week Low
$29.31
$61.58
52 Week High
$69.33
$116.66

Technical Indicators

Market Signals
Indicator
CYTK
ORA
Relative Strength Index (RSI) 49.62 50.17
Support Level $59.37 $107.09
Resistance Level $63.80 $112.19
Average True Range (ATR) 2.56 2.77
MACD -0.44 -0.44
Stochastic Oscillator 42.46 38.98

Price Performance

Historical Comparison
CYTK
ORA

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

Share on Social Networks: